Classifying toxicity and pathology by gene-expression profile – taking a lead from studies in neoplasia
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (8) , 388-393
- https://doi.org/10.1016/s0165-6147(02)02028-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Identification of toxicologically predictive gene sets using cDNA microarraysMolecular Pharmacology, 2001
- Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential22Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Cy, Cyanine; DLCL, diffuse large cell lymphoma; dNTPs, deoxyribonucleotides; ESTs, expressed sequence tags; mRNA, messenger RNA; NHL, non-Hodgkin’s lymphoma; ORF, open reading frame; RT-PCR, reverse transcription-polymerase chain reaction; and 17AAG, 17-allylamino,17-demethoxygeldanamycin.Biochemical Pharmacology, 2001
- Towards a novel classification of human malignancies based on gene expression patternsThe Journal of Pathology, 2001
- Microarrays—the 21st century divining rod?Nature Medicine, 2001
- Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistanceOncogene, 2001
- Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicityToxicology Letters, 2001
- Molecular portraits of human breast tumoursNature, 2000
- Genomics, gene expression and DNA arraysNature, 2000
- Microarrays and toxicology: The advent of toxicogenomicsMolecular Carcinogenesis, 1999
- Making and reading microarraysNature Genetics, 1999